Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected...

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• Left main coronary artery occlusion during acute myocardial infarction (AMI) carries high mortality and adverse cardiovascular event risks.
• Primary percutaneous coronary intervention (PCI) is standard, but deferred stent implantation is explored to mitigate complications like distal embolization.
• No randomized trials have directly compared deferred versus immediate stenting for unprotected left main coronary artery occlusion in AMI.

Purpose of the Study:

• To evaluate the clinical performance and patient outcomes of deferred stenting compared to immediate stenting.
• To determine if a deferred stenting strategy reduces mortality and major adverse cardiovascular events in AMI patients with left main occlusion.

Main Methods:

• The Optimal Strategy of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction due to Unprotected Left Main Coronary Artery Occlusion (OPTIMAL) study is an open-label, randomized, multicenter trial.
• 480 patients with AMI from left main coronary artery occlusion will be randomized 1:1 to immediate stenting or deferred stenting (4-10 days post-angioplasty).
• Primary endpoint: composite of all-cause mortality or recurrent MI at 30 days. Secondary endpoints include mortality, cardiac death, recurrent MI, and revascularization at various time points.

Main Results:

• This section is not yet available as the study is likely ongoing or results are pending.

Conclusions:

• The OPTIMAL study aims to provide crucial data on the efficacy and safety of deferred stenting versus immediate stenting for acute myocardial infarction due to unprotected left main coronary artery occlusion.